Gubra A/S raised financial guidance for full-year 2023. For the period, organic revenue growth is now expected to be 16-21% (previously around 10%).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
326 DKK | -0.61% | +2.19% | +160.80% |
07/05 | Gubra A/S Announces Management Changes | CI |
17/04 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
1st Jan change | Capi. | |
---|---|---|
+160.80% | 780M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- GUBRA Stock
- News Gubra A/S
- Gubra A/S Raises Financial Guidance for Full-Year 2023